Adult ADHD Self Report Scale

Abstract

The Adult ADHD Self-Report Scale (ASRS-v1.1) is an 18-item psychometric screening and symptom-frequency assessment instrument developed in conjunction with the World Health Organization (WHO) and the Workgroup on Adult Attention-Deficit/Hyperactivity Disorder. Designed to map directly onto the diagnostic criteria codified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), the scale assesses the manifestations of adult ADHD across two primary symptom domains: Inattention (9 items) and Hyperactivity-Impulsivity (9 items). The tool is bifurcated into a 6-item screening subset (Part A)—identified via stepwise logistic regression to optimize diagnostic sensitivity and specificity—and a subsequent 12-item inventory (Part B) that captures supplementary symptom frequencies and nuances in clinical presentation. Administered via a 5-point Likert response format (ranging from Never to Very Often), the ASRS-v1.1 exhibits robust psychometric properties across both community and clinical populations. Published validation studies demonstrate high internal consistency (Cronbach’s alpha typically ranging between α = .88 and .93 for the full scale), excellent test-retest reliability (intraclass correlation coefficients > .80), and an area under the receiver operating characteristic curve (AUC) between .82 and .90 against structured clinical interviews. This article provides a comprehensive academic review of the scale’s theoretical underpinnings, structural validity, factor analytic profile, psychometric reliability, clinical utility, scoring algorithms, and full item specifications.

Keywords

Adult ADHD Self-Report Scale, ASRS-v1.1, Attention-Deficit/Hyperactivity Disorder, Psychometrics, Executive Dysfunction, Diagnostic Screening, Inattention, Hyperactivity-Impulsivity, World Health Organization, Clinical Assessment

Authors

The Adult ADHD Self-Report Scale (ASRS-v1.1) was developed under the auspices of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI) Advisory Committee and the Workgroup on Adult ADHD. The primary investigative team and key psychometric collaborators include:

• Ronald C. Kessler, Ph.D. – Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
• Lenard A. Adler, M.D. – Departments of Psychiatry and Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.
• Michael J. Ames, Ph.D. – Eli Lilly and Company, Indianapolis, Indiana, USA.
• Ovsanna Demler, M.S. – Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
• Stephen V. Faraone, Ph.D. – Departments of Psychiatry and Neuroscience & Physiology, SUNY Upstate Medical University, Syracuse, New York, USA.
• Eva Hiripi, M.S. – Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
• Mary Jane Howes, Ph.D. – Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
• Robert Jin, M.A. – Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.
• Katerine Secnik, Ph.D. – Eli Lilly and Company, Indianapolis, Indiana, USA.
• Thomas J. Spencer, M.D. – Pediatric Psychopharmacology Clinical and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
• David J. Stein, M.D., Ph.D. – Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
• Ellen E. Walters, M.S. – Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA.

Primary Administrative Contact: Requests for permission to reproduce or distribute the scale are administered through the Department of Health Care Policy at Harvard Medical School (Email: [email protected]).

Purpose

The primary purpose of the Adult ADHD Self-Report Scale (ASRS-v1.1) is to provide a standardized, psychometrically validated, and clinically actionable instrument for detecting attention-deficit/hyperactivity symptoms in adult populations. Historically conceptualized as a disorder restricted to childhood and adolescence, ADHD is now well established as a chronic neurodevelopmental condition that persists into adulthood in approximately 50% to 65% of cases. However, diagnosing adult ADHD presents significant diagnostic challenges. Adult manifestations of the disorder diverge substantially from the prototypical disruptive motor behaviors seen in young children; adults frequently present with pervasive executive dysfunction, internal cognitive restlessness, severe chronic procrastination, time-management failures, emotional dysregulation, and occupational impairments.

In response to widespread underdiagnosis and misdiagnosis in primary care and general psychiatric settings, the WHO Workgroup formulated the ASRS-v1.1 to accomplish three complementary objectives:

1. Rapid Population-Level Screening and Case Identification: The 6-item short form (Part A) was statistically optimized to serve as an ultra-brief triage tool. It allows primary care clinicians, occupational health practitioners, and epidemiological researchers to rapidly screen individuals for high likelihood of adult ADHD in under three minutes, determining whether an exhaustive clinical evaluation is indicated.
2. Symptom Severity and Domain Profiling: The complete 18-item instrument measures the specific dimensional severity across both the Inattention and Hyperactivity-Impulsivity domains. This enables clinicians to delineate predominantly inattentive, predominantly hyperactive-impulsive, or combined symptom profiles, aligning with established categorical classification criteria.
3. Treatment Monitoring and Longitudinal Outcomes: Because the ASRS evaluates symptom frequency over a recent timeframe (typically the past 6 months or past 30 days depending on study protocol), it serves as a reliable repeated-measures metric to gauge therapeutic response to pharmacological (e.g., psychostimulants, atomoxetine) and psychosocial (e.g., cognitive behavioral therapy for adult ADHD) interventions.

Psychological Construct

The ASRS-v1.1 measures the overarching psychological construct of Adult Attention-Deficit/Hyperactivity Disorder, operationalized through two core latent dimensions:

1. Inattention and Executive Cognitive Dysfunction (Items 1, 2, 3, 4, 7, 8, 9, 10, 11)

This subscale captures deficits in working memory, sustained attention, selective attention, task initiation, and organizational execution. In adulthood, inattention rarely presents simply as daydreaming; instead, it manifests as severe impairment in handling complex, multistep professional and household demands. Specific construct facets assessed include:

• Deficits in Task Completion and Closure (Item 1): Difficulty wrapping up the final details of projects once the challenging cognitive elements have been resolved, reflecting impaired persistence and goal-directed follow-through.
• Organizational Inability (Item 2): Impairments in structuring tasks that require systematic planning, prioritization, and sequencing of actions.
• Prospective Memory Failures (Item 3): Chronic failure to remember appointments, meetings, billing dates, and daily obligations, reflecting prospective working memory deficits.
• Procrastination and Activation Paralysis (Item 4): Avoidance, dread, or delay in initiating tasks that demand sustained mental effort or high executive bandwidth.
• Careless Errors and Attention to Detail (Item 7): Tendency to commit avoidable errors during routine, repetitive, or tedious activities due to lapses in vigilance.
• Sustained Cognitive Fatigue (Item 8): Inability to maintain cognitive focus during monotonous, lengthy tasks.
• Auditory Distractibility and Active Listening Lapses (Item 9): Mind-wandering and difficulty focusing on direct interpersonal verbal communication.
• Misplacement of Functional Objects (Item 10): Losing essential daily items (e.g., keys, wallets, phones, documents) due to encoding lapses during automatic activities.
• External Distractibility (Item 11): Susceptibility to ambient sensory stimuli (unrelated noises, visual clutter, environmental movements) disrupting current task engagement.

2. Hyperactivity, Motor Restlessness, and Impulsivity (Items 5, 6, 12, 13, 14, 15, 16, 17, 18)

This subscale assesses the behavioral and subjective manifestations of hyperactivity and response inhibition failure. In adults, overt behavioral hyperactivity typically morphs into subjective feelings of inner tension, verbal overactivity, and behavioral impatience:

• Extremity Fidgeting (Item 5): Involuntary motor overflow, such as tapping feet, drumming fingers, or squirming while seated.
• Subjective Inner Drive and Hyperkinesia (Item 6): A pervasive feeling of being uncomfortably driven by a motor or compelled to remain perpetually engaged in activity.
• Situational Motor Non-Compliance (Item 12): Inability to remain seated in settings where seating is expected (e.g., business meetings, lectures, formal gatherings).
• Internalized Restlessness (Item 13): Subjective feelings of being internally on edge, tense, or unable to remain still.
• Relaxation Inability (Item 14): Pronounced difficulty unwinding, disengaging from stimulation, or enjoying leisure activities peacefully during downtime.
• Verbal Disinhibition and Logorrhea (Item 15): Excessive talking across social, personal, and professional contexts.
• Conversational Impatience and Intrusiveness (Item 16): Prematurely finishing other people’s sentences or blurting out responses before interlocutors conclude their thoughts.
• Delay Aversion and Turn-Taking Impairment (Item 17): Extreme intolerance of queuing, waiting in line, or awaiting one’s turn in structured activities.
• Social Boundary Disinhibition (Item 18): Interjecting into or interrupting ongoing conversations, meetings, or activities when others are busy.

Theoretical Framework

The conceptual architecture of the ASRS-v1.1 is rooted in the neurodevelopmental and cognitive models of executive functioning pioneered by Russell A. Barkley, as well as the diagnostic nosology established by the American Psychiatric Association. In Barkley’s Unified Theory of ADHD, the core deficit in ADHD is not fundamentally an attention deficit per se, but rather an impairment in behavioral inhibition. Behavioral inhibition encompasses three interlocked processes: (1) inhibiting the initial prepotent response to an event; (2) stopping an ongoing response, thereby permitting a delay; and (3) interference control (protecting the delay and self-directed actions from internal and external disruptions).

According to this theoretical paradigm, behavioral inhibition provides the necessary temporal foundation for four critical executive functions:

1. Working Memory: Holding mental representations active for prospective planning and retrospection.
2. Self-Regulation of Affect, Motivation, and Arousal: Mobilizing intrinsic motivation when external rewards are delayed.
3. Internalization of Speech: Using internal self-talk for rule-following, behavioral guidance, and reflective problem-solving.
4. Reconstitution: The analysis and synthesis of behavioral scripts into novel, goal-directed actions.

In adults, childhood gross motor hyperactivity diminishes as cortical maturation occurs, yet the underlying deficit in behavioral inhibition remains intact. Consequently, the individual experiences failures in time awareness, forward planning, response inhibition, and intrinsic task persistence. The ASRS-v1.1 operationalizes this developmental shift by translating childhood behavioral criteria (such as “runs about or climbs excessively”) into ecologically valid adult manifestations (such as “trouble wrapping up final details” or “difficulty unwinding and relaxing”). This alignment ensures the measurement model captures adult neuropsychological reality without sacrificing fidelity to DSM criteria.

Validity

The psychometric validity of the ASRS-v1.1 has been rigorously evaluated across epidemiological, clinical, and community cohorts globally.

Criterion and Diagnostic Validity

In the seminal validation study conducted by Kessler et al. (2005) using data from the National Comorbidity Survey Replication (NCS-R; N = 3,197), the 6-item Part A screener demonstrated exceptional diagnostic concordance with blind clinical re-interviews based on the semi-structured ADHD module of the Structured Clinical Interview for DSM-IV (SCID). Receiver Operating Characteristic (ROC) analyses revealed an Area Under the Curve (AUC) of 0.82 to 0.90 in community samples and upwards of 0.92 in specialized clinical cohorts. Using the recommended dichotomous scoring threshold, the 6-item screener achieved a diagnostic sensitivity of 68.7% and a specificity of 99.5% in general population estimates, yielding a total classification accuracy of 97.9%.

Convergent and Discriminant Validity

Convergent validity has been established through strong, statistically significant correlations with other gold-standard adult ADHD measures:

• Correlation with the Conners’ Adult ADHD Rating Scales (CAARS): r = .76 to .84 (p < .001).
• Correlation with the Wender Utah Rating Scale (WURS) retrospective childhood assessment: r = .58 to .69 (p < .001).
• Correlation with the Barkley Adult ADHD Rating Scale-IV (BAARS-IV): r = .81 to .87 (p < .001).

Discriminant validity is supported by studies examining clinical populations with comorbid conditions. While scores on the ASRS are modestly elevated in individuals with major depressive disorder, generalized anxiety disorder, and bipolar disorder, multivariable logistic regressions demonstrate that the ASRS continues to explain unique diagnostic variance attributable specifically to ADHD symptoms, effectively differentiating primary attentional dysfunction from generalized affective distress (Adler et al., 2006).

Reliability

The ASRS-v1.1 demonstrates high reliability across diverse cultural, linguistic, and clinical settings.

Internal Consistency

Across multiple published psychometric evaluations, internal consistency estimates have consistently exceeded recommended standards for clinical instruments:

• Total 18-Item Scale: Cronbach’s alpha values typically fall between α = .88 and .94. In a representative clinical evaluation by Adler et al. (2006), Cronbach’s alpha for the overall scale was .88 in treated patients and .93 in active ADHD cohorts.
• Inattention Subscale: Internal consistency ranges between α = .83 and .89.
• Hyperactivity-Impulsivity Subscale: Internal consistency ranges between α = .77 and .86.
• 6-Item Part A Screener: Demonstrates high internal consistency despite its brevity, with Cronbach’s alpha values typically reported between α = .72 and .82, and McDonald’s omega (ω) values exceeding .75.

Test-Retest Reliability

Stability across repeated administrations without intervention is strong. In test-retest evaluations over intervals ranging from 1 to 4 weeks, intraclass correlation coefficients (ICC) and Pearson correlation coefficients consistently demonstrate high temporal stability:

• Total scale test-retest correlation: r = .85 to .91 (p < .001).
• Part A screener test-retest correlation: r = .83 (p < .001).
• Subscale test-retest reliability: Inattention ICC = .86; Hyperactivity-Impulsivity ICC = .81.

Factor Analysis

Extensive exploratory factor analyses (EFA) and confirmatory factor analyses (CFA) have examined the latent structure of the 18 items comprising the ASRS-v1.1. The empirical literature broadly supports a correlated two-factor model, mirroring the formal DSM-IV/DSM-5 diagnostic taxonomy, as well as a bifactor model representing a strong general ADHD factor alongside two distinct group factors.

Confirmatory Factor Analytic Fit

In large-scale structural equation modeling studies (e.g., Kessler et al., 2005, 2007; Kim et al., 2013), the two-factor specification yields satisfactory goodness-of-fit indices:

• Comparative Fit Index (CFI): .92 – .96
• Tucker-Lewis Index (TLI): .91 – .95
• Root Mean Square Error of Approximation (RMSEA): .042 – .058 (90% CI: .038 – .064)
• Standardized Root Mean Square Residual (SRMR): .039 – .048

Factor Loadings

Factor loadings on their respective primary dimensions are consistently robust:

• Inattention Factor (Items 1, 2, 3, 4, 7, 8, 9, 10, 11): Standardized factor loadings generally range between λ = .55 and .82. Items 1 (“trouble wrapping up final details”), 2 (“difficulty getting things in order”), and 8 (“difficulty keeping attention on boring/repetitive work”) systematically demonstrate the highest loadings (> .75), indicating high discriminant power for inattentive pathology.
• Hyperactivity-Impulsivity Factor (Items 5, 6, 12, 13, 14, 15, 16, 17, 18): Standardized factor loadings generally range between λ = .48 and .78. Items 5 (“fidget or squirm”), 6 (“driven by a motor”), and 13 (“restless or fidgety”) consistently emerge as the central markers of the hyperactivity domain.

The inter-factor correlation between Inattention and Hyperactivity-Impulsivity is typically moderate to high (r = .55 to .72), affirming that while they represent separable psychopathological dimensions, they share substantial variance under the broader neurodevelopmental construct of adult ADHD.

Instrument / Measurement Tool

• Test Type: Standardized Clinical and Epidemiological Self-Report Rating Scale.
• Item Count: 18 items total (divided into Part A: 6 items, and Part B: 12 items).
• Administration Format: Paper-and-pencil, computer-assisted self-interview (CASI), or clinical electronic health record integration.
• Completion Time: Approximately 3 to 5 minutes for the full 18-item scale; under 2 minutes for the 6-item Part A screener.
• Target Population: Adults aged 18 years and older (adaptations exist for transitional-age youth).
• Response Scale: 5-point Likert frequency scale: Never, Rarely, Sometimes, Often, Very Often.
• Scoring Paradigms:
  • Continuous Scoring: Responses can be scored numerically from 0 to 4 (Never = 0, Rarely = 1, Sometimes = 2, Often = 3, Very Often = 4). Total score ranges from 0 to 72. Inattention subscale ranges from 0 to 36; Hyperactivity-Impulsivity subscale ranges from 0 to 36.
  • Categorical / Shaded Screener Scoring (Part A): In standard clinical practice, items are evaluated dichotomously based on whether the response falls in the clinically significant range (often indicated by grey shading on the diagnostic sheet):
    • Items 1, 2, 3: Significant if rated Sometimes, Often, or Very Often.
    • Items 4, 5, 6: Significant if rated Often or Very Often.

    A score of 4 or more positive responses out of 6 in Part A indicates a high likelihood of adult ADHD and warrants comprehensive clinical diagnostic interview.

Permissions & Fee and Test Year

• Publication Year: Developed in 2001; primary normative and validation data published in 2003 and 2005.
• Copyright: © World Health Organization (WHO), 2001, 2003. Based on the Composite International Diagnostic Interview (© 2001 World Health Organization).
• Fee: Free for clinical, non-commercial research, and educational purposes.
• Commercial Licensing & Translation Permissions: Commercial use, modification, digital health deployment, or unauthorized distribution requires formal licensing permission. Requests for permissions should be directed to:
  
  Professor Ronald C. Kessler, Ph.D.
  Department of Health Care Policy, Harvard Medical School
  Fax: +1 617-432-3588 | Email: [email protected]
  Web: http://www.hcp.med.harvard.edu/ncs/asrs.php

References

• Adler, L. A., Spencer, T., Faraone, S. V., Kessler, R. C., Howes, M. J., Biederman, J., & Secnik, K. (2006). Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Annals of Clinical Psychiatry, 18(3), 145–148. https://doi.org/10.1080/10401230600801077
• American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). American Psychiatric Association.
• Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65–94. https://doi.org/10.1037/0033-2909.121.1.65
• Barkley, R. A. (1998). Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment (2nd ed.). Guilford Press.
• Biederman, J., Faraone, S. V., Spencer, T., Wilens, T., Norman, D., Lapey, K. A., Mick, E., Lehman, B. K., & Doyle, A. (1993). Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 150(12), 1792–1798. https://doi.org/10.1176/ajp.150.12.1792
• Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J., Jin, R., Secnik, K., Spencer, T., Stein, D. J., & Walters, E. E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245–256. https://doi.org/10.1017/s0033291704002892
• Kessler, R. C., Adler, L. A., Gruber, M. J., Sarawate, C. A., Spencer, T., & Van Brunt, D. L. (2007). Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. International Journal of Methods in Psychiatric Research, 16(2), 52–65. https://doi.org/10.1002/mpr.208
• Schweitzer, J. B., Cummins, T. K., & Kant, C. A. (2001). Attention-deficit/hyperactivity disorder. Medical Clinics of North America, 85(3), 757–777. https://doi.org/10.1016/s0025-7125(05)70339-0

Items of the Scale